Sanofi’s treatment for hemophilia that can be administered as infrequently as once every other month, was approved by the US ...
MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback